JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB55811

Anti-C5b-9 antibody

3

(4 Reviews)

|

(103 Publications)

Anti-C5b-9 antibody (ab55811) is a rabbit polyclonal antibody detecting C5b-9 in IHC-P, ICC/IF. Suitable for Human.

- Over 80 publications
- Trusted since 2007

View Alternative Names

CPAMD4, C5, Complement C5, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4

4 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-C5b-9 antibody (AB55811)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-C5b-9 antibody (AB55811)

ab55811 staining C5b-9 in human liver.
Left panel : with primary antibody at 4 ug/ml. Right panel : isotype control.
Sections were stained using an automated system (DAKO Autostainer Plus ), at room temperature : sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffers citrate pH6.1 in a DAKO PT link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.

Immunocytochemistry/ Immunofluorescence - Anti-C5b-9 antibody (AB55811)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-C5b-9 antibody (AB55811)

ICC/IF image of ab55811 stained HeLa cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab55811, 1μg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-C5b-9 antibody (AB55811)
  • IHC-P

AbReview77864****

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-C5b-9 antibody (AB55811)

Immunohistochemical analysis of paraffin-embedded Human placenta tissue labeling C5b-9 with ab55811 at 1/100 dilution (24h at 4°C ) followed by Goat anti Rabbit Alexa Fluor® 488 at 1/1000 dilution (Green).

Red channel corresponds to Evans Blue and white channel is the fluorescence obtained from nuclear counterstain DAPI staining.

Heat mediated antigen retrieval using Bio SB ImmunoRetriever with citrate

This image is courtesy of an Abreview submitted by Marcelo Pelajo Machado

Immunohistochemistry - Anti-C5b-9 antibody (AB55811)
  • IHC

CiteAb

Immunohistochemistry - Anti-C5b-9 antibody (AB55811)

C5b-9 immunohistochemistry using Anti-C5b-9 antibody ab55811. Publication image and figure legend from Yang, H., Li, G., et al., 2024, Front Immunol, PubMed 39483473

C5a-C5aR pathway activation in human breast cancer and its role in ferroptosis resistance and breast cancer progression in 4T-1 xenograft mouse model. (A), the expression of C5b-9 and C5aR in BC tumoral tissues (T) and BC-adjacent non-tumoral tissues (N) of patients with different clinical stages were evaluated by immunohistochemistry. Statistical analyses of the difference of C5b-9 and C5aR expression between different groups were presented in the right. Statistical differences are assessed by student’s t-test. Data were mean ± s.e.m. *, p < 0.05, **, p < 0.01, ***, p < 0.001, ****, p < 0.001.

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, ICC/IF

applications

Immunogen

Native Full Length Protein corresponding to Human C5.

P01031

Specificity

This antibody is monospecific for C5b-9 complex in purified form or present in cobra venom factor activated human serum. There is no reactivity vs. non-activated normal human serum or plasma

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval via the pressure cooker method before commencing with IHC staining protocol.", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" } } }

Product details

Anti-C5b-9 antibody (ab55811) is a rabbit polyclonal antibody and is validated for use in ICC/IF, IHC-P.

Anti-C5b-9 antibody (ab55811) has been cited over 82 times in peer reviewed journals and is trusted by the scientific community.

Abcam's high quality validation processes ensure Anti-C5b-9 antibody (ab55811) has high sensitivity and specificity.

Anti-C5b-9 antibody (ab55811) has 4 independent reviews from customers.

Anti-C5b-9 antibody (ab55811) specifically detects C5b-9 (UniProt ID: P13671; Molecular weight: 102kDa) and is sold in 100 µg selling sizes. The C5b-9 complement complex is a membrane attack complex that's part of the body's innate and acquired immune system and is formed when the complement system is activated.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Purification notes
This antibody is provided as IgG fraction. Please note that the concentration value refers to the fraction.
Storage buffer
pH: 7.2 Preservative: 0.1% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

C5b-9 also known as the membrane attack complex (MAC) serves as a critical component in the immune system's defense mechanism. Composed of proteins C5b C6 C7 C8 and multiple units of C9 this complex forms on the surface of pathogen membranes. It typically weighs approximately 900 kDa. The MAC largely expresses on cell membranes during immune responses and primarily targets bacterial pathogens by creating pores that lead to cell lysis.
Biological function summary

C5b-9 functions as part of the larger complement system which aids in innate immunity. The process begins once C5b initiates the assembly of the complex by binding to C6 C7 C8 and finally incorporating C9 molecules. These form a pore-like structure leading to increased permeability of the target cell membrane resulting in the disruption and elimination of the pathogen.

Pathways

C5b-9 plays a critical role in the complement cascade an essential pathway in the immune system. This cascade consists of several steps including the alternative and classical pathways. C5b-9 is related to the protein C3 through these pathways which upon activation helps facilitate C5 activation. This connection highlights its importance in promoting pathogen clearance.

C5b-9 has associations with conditions such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). In PNH excessive formation of this complex on red blood cells leads to their destruction contributing to hemolysis. Similarly in aHUS dysregulation of the complement system including C5b-9 causes damage to endothelial cells. This complex connects with proteins like factor H and CD59 whose dysfunction or deficiency can lead to or exacerbate these diseases.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Activation of C5 by a C5 convertase initiates the spontaneous assembly of the late complement components, C5-C9, into the membrane attack complex. C5b has a transient binding site for C6. The C5b-C6 complex is the foundation upon which the lytic complex is assembled.. C5a anaphylatoxin. Derived from proteolytic degradation of complement C5, C5a anaphylatoxin is a mediator of local inflammatory process. Binding to the receptor C5AR1 induces a variety of responses including intracellular calcium release, contraction of smooth muscle, increased vascular permeability, and histamine release from mast cells and basophilic leukocytes (PubMed : 8182049). C5a is also a potent chemokine which stimulates the locomotion of polymorphonuclear leukocytes and directs their migration toward sites of inflammation.
See full target information C5

Publications (103)

Recent publications for all applications. Explore the full list and refine your search

Haematologica : PubMed40820810

2025

KLF4 overexpression protects against complement-mediated endothelial injury in transplant-associated thrombotic microangiopathy.

Applications

Unspecified application

Species

Unspecified reactive species

Shuhui Jiang,Jiaqian Qi,Tingting Pan,Zhenzhen Yao,Siyi Lu,Yifei Han,Depei Wu,Yue Han

Nature communications 16:1506 PubMed39929829

2025

Enzymatic conversion of blood group B kidney prevents hyperacute antibody-mediated injuries in ABO-incompatible transplantation.

Applications

Unspecified application

Species

Unspecified reactive species

Jun Zeng,Ming Ma,Xiaojuan Jiang,Zhengsheng Rao,Dan Huang,Hao Zhang,Saifu Yin,Rong Bao,Haohan Zhang,Zhiling Wang,Hongwei Gao,Feng Gong,Tao Lin,Keqin Zhang,Turun Song

Chemical biology & drug design 105:e70032 PubMed39928525

2025

Potential Modulatory Effects of Hesperidin on the JAK/STAT Pathway in Mesangial Proliferative Glomerulonephritis.

Applications

Unspecified application

Species

Unspecified reactive species

Yingchun Tang,Jing Zhang,Zhengxiang Wang,Xiongjun Dong

Frontiers in immunology 15:1470907 PubMed39877352

2025

Terminal complement complex deposition on chondrocytes promotes premature senescence in age- and trauma-related osteoarthritis.

Applications

Unspecified application

Species

Unspecified reactive species

Leonie Ruths,Jana Hengge,Graciosa Q Teixeira,Melanie Haffner-Luntzer,Anita Ignatius,Jana Riegger

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 39:e70272 PubMed39777689

2025

The C3/C3aR pathway exacerbates acetaminophen-induced mouse liver injury via upregulating podoplanin on the macrophage.

Applications

Unspecified application

Species

Unspecified reactive species

Zhanli Xie,Jiang Jiang,Fei Yang,Jingjing Han,Zhenni Ma,Tao Wen,Xia Bai

Scientific reports 15:495 PubMed39753879

2025

Complement classical and alternative pathway activation contributes to diabetic kidney disease progression: a glomerular proteomics on kidney biopsies.

Applications

Unspecified application

Species

Unspecified reactive species

Yang Yang,Ying Zhang,Yuan Li,Xinjin Zhou,Kazuho Honda,Dedong Kang,Muxi Wang,Jing-Hua Yang,Zongping Xia,Yuan Wei,Lu Liu,Ruimin Hu,Takashi Takaki,Guolan Xing

Frontiers in immunology 15:1466180 PubMed39483473

2024

A novel hollow iron nanoparticle system loading PEG-FeO with C5a receptor antagonist for breast cancer treatment.

Applications

Unspecified application

Species

Unspecified reactive species

Hong Yang,Guiqing Li,Ji Zhang,Jing Zhao,Yunpei Zhao,Yufei Wu,Zihan Sun,Shuangshuang Song,Ying Zou,Zhihao Zou,Xiao Han,Boshao Deng,Lulu Wang,Hang Rao,Guilian Xu,Shufeng Wang,Sheng Guo,Huanyu Ding,Yan Shi,Yuzhang Wu,Jian Chen

BMC nephrology 25:387 PubMed39478440

2024

The prognostic role of activation of the complement pathways in the progression of advanced IgA nephropathy to end-stage renal disease.

Applications

Unspecified application

Species

Unspecified reactive species

Ying Wang,Shimin Jiang,Dingxin Di,Guming Zou,Hongmei Gao,Shunlai Shang,Wenge Li

European thyroid journal 13: PubMed39316722

2024

IgG4 glycosylation contributes to the pathogenesis of IgG4 Hashimoto's thyroiditis via the complement pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Chenxu Zhao,Zhiming Sun,Shuaihang Wang,Jixin Zhang,Jumei Liu,Lei Chen,Guizhi Lu,Yang Yu,Ying Gao

International journal of molecular sciences 25: PubMed39273570

2024

Complement-Mediated Two-Step NETosis: Serum-Induced Complement Activation and Calcium Influx Generate NADPH Oxidase-Dependent NETs in Serum-Free Conditions.

Applications

Unspecified application

Species

Unspecified reactive species

Maria Maqsood,Samuel Suntharalingham,Meraj Khan,Carolina G Ortiz-Sandoval,Wouter J C Feitz,Nades Palaniyar,Christoph Licht
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com